The way a medicine is processed in the body is known as pharmacokinetics. So, how is the medicine absorbed, how is it dispersed throughout the body, where is it disseminated, how is it metabolized, and how is it eliminated? It is primarily concerned with the medication and the human body. The intricate interactions between the drug, the human body, and then the pathogen that may be causing an infection in the patient are taken into account by pharmacodynamics. So, how does the antibiotic destroy the pathogen that may be causing the infection, and how can we dose the medicine to maximize that killing activity profile?”
Pharmacokinetics can be defined as "what the body does to the drug." The intensity of a drug's impact in relation to its concentration in a body fluid, usually at the site of action, is referred to as pharmacodynamics. It can be summarized as follows: "what the medicine does to the body."
Title : Pathology and patient safety: The vital role of electronic medical record and pathology informatics in error reduction and precision medicine
Consolato M Sergi, University of Ottawa, Canada
Title : mRNA-based systemically delivered directed gene therapy using nanomaterials
A C Matin, Stanford University, United States
Title : Role of nanoformulations in treating Cystic Fibrosis
Bhupendra Gopalbhai Prajapati, Shree S.K.Patel College of Pharmaceutical Education and Research, India
Title : EU GMP annex1 barrier system and PIC/s annex 2A on cell and gene therapy
Richard Denk, SKAN AG, Switzerland
Title : Pro and con to dermpharm and tox assays- 2023
Howard I Maibach, University of California, United States
Title : Dual GIP/GLP-1 receptor stimulation in treatment of type 2 diabetes mellitus – The ground-breaking 'twincretin' approach
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mucoadhesive electrospun fibrous systems for the fast and sustained delivery of drugs
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Extracellular vesicles as delivery vehicles of therapeutic compounds
Stefania Raimondo, University of Palermo, Italy
Title : Pediatric brain on cannabinoids: Adverse effects of cannabinoid products in children and adolescents
Peter B Chase, Essentia Health- St. Mary's Medical Center, United States
Title : EBV latent membrane protein 1 augments gammer-delta T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules
Yue liu, Hong Kong Baptist University, China